Stephen L. Chan
Chinese University of Hong Kong
ORCID: 0000-0001-8998-5480Also affiliated with Prince of Wales Hospital
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 5 papers. Top paper: “Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma”.
S.L. Chan, R.K. Kelley, G. Lau, M. Kudo, W. Sukeepaisarnjaroen +198 more
Lorenzo Fornaro, Mario Domenico Rizzato, Lorenzo Antonuzzo, Federico Rossari, Tomoyuki Satake +56 more
Peiyong Jiang, Lu Ji, W. K. Jacky Lam, Qing Zhou, Mary-Jane L. Ma +21 more
Zhewen Xiong, Yiling Zhang, Haoran Wu, Jian Cao, Patrick Pak-Chun Wong +9 more
Hao Huang, Aikha Melissa Go Wong, Howard H.W. Leung, Winnie Wing Yan Cheung, Yin Kau Lam +11 more